Dipeptidyl Peptidase-4 Inhibitors and the Risk of Chronic Inflammatory Skin Diseases in Type 2 Diabetes Mellitus in Taiwan: A Nationwide Population-Based Cohort Study.

HSIEN-YI CHIULin, Yu JrYu JrLinHuang, Yu-HueiYu-HueiHuang2024-09-062024-09-062024-03-250022202Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/720837enfalseChronic inflammatory skin diseasesDiabetes mellitusDipeptidyl peptidase-4 inhibitorsDrugNational Health Insurance Research DatabaseDipeptidyl Peptidase-4 Inhibitors and the Risk of Chronic Inflammatory Skin Diseases in Type 2 Diabetes Mellitus in Taiwan: A Nationwide Population-Based Cohort Study.journal article10.1016/j.jid.2024.03.017385379302-s2.0-85195866320